WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Pre-operative Adaptive Short Court Radiation Therapy in Gastric Cancer
Phase 2
Terminated
- Conditions
- Gastric Adenocarcinoma
- Interventions
- Radiation: Adaptive short course radiation therapyDrug: Standard of care chemotherapy regimen
- First Posted Date
- 2019-11-14
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 4
- Registration Number
- NCT04162665
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Harnessing Mobile Technology to Reduce Mental Health Disorders in College Populations
Not Applicable
Completed
- Conditions
- Anxiety DisordersEating DisordersDepressive Disorder
- Interventions
- Device: SilverCloud Health Intervention
- First Posted Date
- 2019-11-14
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 6205
- Registration Number
- NCT04162847
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
πΊπΈPennsylvania State University, State College, Pennsylvania, United States
πΊπΈPalo Alto University, Palo Alto, California, United States
Effect of Pea Fiber Supplementation on the Gut Microbiota and Host Metabolome and Proteome (FIB)
Not Applicable
Completed
- Conditions
- Microbial Colonization
- Interventions
- Other: Low fiber dietOther: Pea Fiber Bar
- First Posted Date
- 2019-11-12
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 13
- Registration Number
- NCT04159259
- Locations
- πΊπΈ
Tara Wilmot, Saint Louis, Missouri, United States
EBUS-Miniforceps Biopsy Specimen Acquisition for PD-L1 Testing in Nonsmall Cell Lung Cancer
Not Applicable
Completed
- Conditions
- NSCLCNon Small Cell Lung Cancer
- Interventions
- Device: CoreDx Pulmonary Mini-Forceps
- First Posted Date
- 2019-11-12
- Last Posted Date
- 2023-03-01
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT04159025
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design
Not Applicable
Completed
- Conditions
- Hypertension
- Interventions
- Other: Evidence-based fixed-dose combination protocol based treatment
- First Posted Date
- 2019-11-08
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 21922
- Registration Number
- NCT04158154
- Locations
- π³π¬
Central PHC, Abaji, Nigeria
π³π¬Paikon PHC, Gwagwalada, Nigeria
π³π¬Yimi PHC, Gwagwalada, Nigeria
Cerebral Oxygen Metabolism in Children
Not Applicable
Recruiting
- Conditions
- Cerebral StrokeSickle Cell Disease
- Interventions
- Other: Carbon Dioxide
- First Posted Date
- 2019-11-08
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 350
- Registration Number
- NCT04157179
- Locations
- πΊπΈ
Washington University of St. Louis, Saint Louis, Missouri, United States
Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma
Phase 2
Withdrawn
- Conditions
- Multiple Myeloma
- Interventions
- Biological: Dara-SCProcedure: Blood for research assessmentsProcedure: Bone marrow for research assessments
- First Posted Date
- 2019-11-05
- Last Posted Date
- 2022-01-24
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT04150692
PET/MR for Rectal Cancer Treatment Monitoring and Surveillance
Not Applicable
Terminated
- Conditions
- Cancer of the RectumRectal Cancer
- Interventions
- Device: FDG PET/MRI
- First Posted Date
- 2019-11-05
- Last Posted Date
- 2023-02-14
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 14
- Registration Number
- NCT04150705
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia
Phase 2
Completed
- Conditions
- Hereditary Hemorrhagic Telangiectasia
- Interventions
- Drug: Placebo Gel
- First Posted Date
- 2019-10-25
- Last Posted Date
- 2021-08-24
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 27
- Registration Number
- NCT04139018
- Locations
- πΊπΈ
Washington University, Saint Louis, Missouri, United States
Palliative Lattice Stereotactic Body Radiotherapy (SBRT)
Not Applicable
Completed
- Conditions
- CancerPalliative Radiotherapy
- Interventions
- Radiation: Lattice stereotactic body radiation therapyProcedure: Peripheral blood
- First Posted Date
- 2019-10-21
- Last Posted Date
- 2021-11-22
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT04133415
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Β© Copyright 2025. All Rights Reserved by MedPath